Recurring Consumables ModelTarsons' core model sells consumable labware that is consumed and repurchased frequently by research, clinical, and industrial labs. This creates durable, repeatable demand and higher customer lifetime value; combined with a broad catalogue it supports predictable revenues and steady unit volumes.

Strong Revenue And Margin ProfileA ~32% top-line expansion and robust gross/EBITDA margins indicate operational scale and pricing power in lab consumables. Durable margin structure supports reinvestment in manufacturing and distribution capacity, enabling sustainable growth and the ability to fund long-term initiatives without eroding profitability.

Moderate Leverage, Strong Equity BaseModerate leverage and a high equity ratio provide financial flexibility to fund capex, absorb demand shocks, and pursue measured expansion. A balanced capital structure reduces refinancing risk and supports multi‑quarter resilience, allowing management to prioritize long‑term investments over short-term liquidity fixes.

Bears Say

Negative Free Cash FlowDespite operating cash generation, Tarsons reported negative free cash flow in 2025, implying capex or working capital absorption. Persistent negative FCF limits the firm's ability to self-fund growth, pay down debt, or return capital; fixing FCF requires better capex discipline or working capital management.

Low Return On EquityAn ROE of ~4.7% signals the company is generating modest profits relative to shareholder equity. Low ROE can constrain long-term shareholder returns and suggests inefficiencies in leveraging assets or pricing. Improving margins, asset turnover, or capital allocation is needed for sustainable value creation.

Earnings Volatility / Declining EPSA steep negative EPS growth rate alongside reported declines in net income indicates earnings volatility despite revenue gains. This disconnect points to margin pressures, cost increases, or one-offs; sustained recovery in EPS is required for durable shareholder value and to validate the top-line momentum.

Tarsons Products Limited News

Tarsons Products Limited Releases Investor Presentation for Q2 2025

Tarsons Products Limited ( ($IN:TARSONS) ) has shared an announcement. Tarsons Products Limited has released its Investor Presentation...

3M ago

Tarsons Products Limited Announces Virtual AGM and Annual Report Release

Tarsons Products Limited ( ($IN:TARSONS) ) has issued an announcement. Tarsons Products Limited has announced the dissemination of...

6M ago

TARSONS FAQ

What was Tarsons Products Limited’s price range in the past 12 months?

Tarsons Products Limited lowest stock price was ₹188.05 and its highest was ₹457.25 in the past 12 months.

What is Tarsons Products Limited’s market cap?

Tarsons Products Limited’s market cap is ₹10.62B.

When is Tarsons Products Limited’s upcoming earnings report date?

Tarsons Products Limited’s upcoming earnings report date is May 25, 2026 which is in 91 days.

How were Tarsons Products Limited’s earnings last quarter?

Tarsons Products Limited released its earnings results on Feb 06, 2026. The company reported ₹0.5 earnings per share for the quarter, the consensus estimate of ₹0.5 by ₹0.

Is Tarsons Products Limited overvalued?

According to Wall Street analysts Tarsons Products Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Tarsons Products Limited pay dividends?

Tarsons Products Limited pays a Notavailable dividend of ₹2 which represents an annual dividend yield of 0.86%. See more information on Tarsons Products Limited dividends here

What is Tarsons Products Limited’s EPS estimate?

Tarsons Products Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Tarsons Products Limited have?

Tarsons Products Limited has 53,206,280 shares outstanding.

What happened to Tarsons Products Limited’s price movement after its last earnings report?

Tarsons Products Limited reported an EPS of ₹0.5 in its last earnings report, expectations of ₹0.5. Following the earnings report the stock price went up 7.105%.

Which hedge fund is a major shareholder of Tarsons Products Limited?

Currently, no hedge funds are holding shares in IN:TARSONS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Tarsons Products Limited

Tarsons Products Limited engages in the manufacturing and trading of plastic laboratory products and scientific instruments in India and internationally. The company's products include disposable plastic labware, centrifuge ware, cryo labware, liquid handling systems, and safety products and instruments; and bottles, carboys, measuring cylinder, cell culture products, electrophoresis, microscopy and microbiology products, vacuum desiccators, mini coolers, cryo boxes, breakers, test tube racks, pipette tips, petri dish, centrifuge tubes, cryogenic and storage vials, pasteur pipettes, vortex, and other products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. The company was incorporated in 1983 and is headquartered in Kolkata, India.